GLP-1 medications may lower epilepsy risk in type 2 diabetes patients

sciencedaily.com

GLP-1 medications like Ozempic may reduce epilepsy risk in type 2 diabetes patients. A new analysis suggests GLP-1 drug users were 16% less likely to develop epilepsy than those on DPP-4 inhibitors, with semaglutide showing the strongest link. Researchers caution this shows an association, not causation, and more studies are needed to confirm the potential neurological benefit.


With a significance score of 5.1, this news ranks in the top 1.3% of today's 31433 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


GLP-1 medications may lower epilepsy risk in type 2 diabetes patients | News Minimalist